Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide

Journal of Virology

Volumn 83, Issue 15, 2009, Pages 7411-7421

  Madu, Ikenna G ^a   Roth, Shoshannah L ^a   Belouzard, Sandrine ^a   Whittaker, Gary R ^a  

^a Cornell University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS FUSION PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL FUSION; CONTROLLED STUDY; HYDROPHOBICITY; MEMBRANE FUSION; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN SECONDARY STRUCTURE; SARS CORONAVIRUS; SEQUENCE ALIGNMENT; VIRION;

AMINO ACID SEQUENCE; ANIMALS; CELL FUSION; CELL LINE; HUMANS; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN STRUCTURE, TERTIARY; SARS VIRUS; SEQUENCE ALIGNMENT; SEVERE ACUTE RESPIRATORY SYNDROME; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

CORONAVIRIDAE; CORONAVIRUS; SARS CORONAVIRUS;

EID: 67650899039     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00079-09     Document Type: Article

References (40)

1. Bartosch, B., J. Dubuisson, and F. L. Cosset. 2003. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J. Exp. Med. 197:633-642.
2. Belouzard, S., V. C. Chu, and G. R. Whittaker. 2009. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc. Natl. Acad. Sci. USA 106:5871-5876.
3. Bernini, A., O. Spiga, A. Ciutti, S. Chiellini, L. Bracci, X. Yan, B. Zheng, J. Huang, M. L. He, H. D. Song, P. Hao, G. Zhao, and N. Niccolai. 2004. Prediction of quaternary assembly of SARS coronavirus peplomer. Biochem. Biophys. Res. Commun. 325:1210-1214.
4. Bosch, B. J., and P. J. Rottier. 2008. Nidovirus Entry into Cells, p. 157-178. In S. Perlman, T. Gallagher, and E. J. Snijder (ed.), Nidoviruses. ASM Press, Washington, DC.
5. Bosch, B. J., R. van der Zee, C. A. de Haan, and P. J. Rottier. 2003. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J. Virol. 77:8801-8811.
6. Chambers, P., C. R. Pringle, and A. J. Easton. 1990. Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins. J. Gen. Virol. 71:3075-3080.
7. Daniel, C., R. Anderson, M. J. Buchmeier, J. O. Fleming, W. J. Spaan, H. Wege, and P. J. Talbot. 1993. Identification of an immunodominant linear neutralization domain on the S2 portion of the murine coronavirus spike glycoprotein and evidence that it forms part of complex tridimensional structure. J. Virol. 67:1185-1194.
8. Durell, S. R., I. Martin, J. M. Ruysschaert, Y. Shai, and R. Blumenthal. 1997. What studies of fusion peptides tell us about viral envelope glycoprotein-mediated membrane fusion (review). Mol. Membr. Biol. 14:97-112.
9. Earp, L. J., S. E. Delos, H. E. Park, and J. M. White. 2005. The many mechanisms of viral membrane fusion proteins. Curr. Top. Microbiol. Immunol. 285:25-66.
10. Freitas, M. S., L. P. Gaspar, M. Lorenzoni, F. C. Almeida, L. W. Tinoco, M. S. Almeida, L. F. Maia, L. Degreve, A. P. Valente, and J. L. Silva. 2007. Structure of the Ebola fusion peptide in a membrane-mimetic environment and the interaction with lipid rafts. J. Biol. Chem. 282:27306-27314.
11. Gomara, M. J., P. Mora, I. Mingarro, and J. L. Nieva. 2004. Roles of a conserved proline in the internal fusion peptide of Ebola glycoprotein. FEBS Lett. 569:261-266.
12. Goodman, M., I. Listowsky, Y. Masuda, and F. Boardman. 1963. Conformational aspects of polypeptides. VIII. Helical assignments via far ultraviolet adsorption spectra and optical activity. Biopolymers 1:33-42.
13. Guillen, J., R. F. de Almeida, M. Prieto, and J. Villalain. 2008. Structural and dynamic characterization of the interaction of the putative fusion peptide of the S2 SARS-CoV virus protein with lipid membranes. J. Phys Chem. B 112:6997-7007.
14. Guillen, J., P. K. Kinnunen, and J. Villalain. 2008. Membrane insertion of the three main membranotropic sequences from SARS-CoV S2 glycoprotein. Biochim. Biophys. Acta 1778:2765-2774.
15. Guillen, J., M. R. Moreno, A. J. Perez-Berna, A. Bernabeu, and J. Villalain. 2007. Interaction of a peptide from the pre-transmembrane domain of the severe acute respiratory syndrome coronavirus spike protein with phospholipid membranes. J. Phys Chem. B 111:13714-13725.
16. Guillen, J., A. J. Perez-Berna, M. R. Moreno, and J. Villalain. 2008. A second SARS-CoV S2 glycoprotein internal membrane-active peptide. Biophysical characterization and membrane interaction. Biochemistry 47:8214-8224.
17. Guillen, J., A. J. Perez-Berna, M. R. Moreno, and J. Villalain. 2005. Identification of the membrane-active regions of the severe acute respiratory syndrome coronavirus spike membrane glycoprotein using a 16/18-mer peptide scan: implications for the viral fusion mechanism. J. Virol. 79:1743-1752.
18. Han, X., J. H. Bushweller, D. S. Cafiso, and L. K. Tamm. 2001. Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin. Nat. Struct. Biol. 8:715-720.
19. Han, X., and L. K. Tamm. 2000. A host-guest system to study structure-function relationships of membrane fusion peptides. Proc. Natl. Acad. Sci. USA 97:13097-13102.
20. Howard, M. W., E. A. Travanty, S. A. Jeffers, M. K. Smith, S. T. Wennier, L. B. Thackray, and K. V. Holmes. 2008. Aromatic amino acids in the juxtamembrane domain of severe acute respiratory syndrome coronavirus spike glycoprotein are important for receptor-dependent virus entry and cell-cell fusion. J. Virol. 82:2883-2894.
21. Klenk, H. D., and W. Garten. 1994. Host cell proteases controlling virus pathogenicity. Trends Microbiol. 2:39-43.
22. Lague, P., B. Roux, and R. W. Pastor. 2005. Molecular dynamics simulations of the influenza hemagglutinin fusion peptide in micelles and bilayers: conformational analysis of peptide and lipids. J. Mol. Biol. 354:1129-1141.
23. Lai, A. L., Y. Li, and L. K. Tamm. 2005. Interplay of proteins and lipids in virus entry by membrane fusion, p. 279-303. In L. K. Tamm (ed.), Protein-lipid interactions. Wiley-VCH Verlag GmbH, Weinheim, Germany.
24. Lee, J. E., M. L. Fusco, A. J. Hessell, W. B. Oswald, D. R. Burton, and E. O. Saphire. 2008. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454:177-182.
25. Lu, Y., T. L. Neo, D. X. Liu, and J. P. Tam. 2008. Importance of SARS-CoV spike protein Trp-rich region in viral infectivity. Biochem. Biophys. Res. Commun. 371:356-360.
26. Martin, I., and J. M. Ruysschaert. 2000. Common properties of fusion peptides from diverse systems. Biosci. Rep. 20:483-500.
27. Perez, L. G., and E. Hunter. 1987. Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein that block processing to gp85 and gp37. J. Virol. 61:1609-1614.
28. Petit, C. M., J. M. Melancon, V. N. Chouljenko, R. Colgrove, M. Farzan, D. M. Knipe, and K. G. Kousoulas. 2005. Genetic analysis of the SARS-coronavirus spike glycoprotein functional domains involved in cell-surface expression and cell-to-cell fusion. Virology 341:215-230.
29. Sainz, B., Jr., J. M. Rausch, W. R. Gallaher, R. F. Garry, and W. C. Wimley. 2005. Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein. J. Virol. 79:7195-7206.
30. Sainz, B., Jr., J. M. Rausch, W. R. Gallaher, R. F. Garry, and W. C. Wimley. 2005. The aromatic domain of the coronavirus class I viral fusion protein induces membrane permeabilization: putative role during viral entry. Biochemistry 44:947-958.
31. Song, H. C., M. Y. Seo, K. Stadler, B. J. Yoo, Q. L. Choo, S. R. Coates, Y. Uematsu, T. Harada, C. E. Greer, J. M. Polo, P. Pileri, M. Eickmann, R. Rappuoli, S. Abrignani, M. Houghton, and J. H. Han. 2004. Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein. J. Virol. 78:10328-10335.
32. Struck, D. K., D. Hoekstra, and R. E. Pagano. 1981. Use of resonance energy transfer to monitor membrane fusion. Biochemistry 20:4093-4099.
33. Taguchi, F., and Y. K. Shimazaki. 2000. Functional analysis of an epitope in the S2 subunit of the murine coronavirus spike protein: involvement in fusion activity. J. Gen. Virol. 81:2867-2871.
34. Tamm, L. K., and X. Han. 2000. Viral fusion peptides: a tool set to disrupt and connect biological membranes. Biosci. Rep. 20:501-518.
35. Volchkov, V. E., H. Feldmann, V. A. Volchkova, and H. D. Klenk. 1998. Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc. Natl. Acad. Sci. USA 95:5762-5767.
36. Watanabe, R., S. Matsuyama, K. Shirato, M. Maejima, S. Fukushi, S. Morikawa, and F. Taguchi. 2008. Entry from cell surface of SARS coronavirus with cleaved S protein as revealed by pseudotype virus bearing cleaved S protein. J. Virol. 82:11985-11991.
37. Wentworth, D. E., and K. V. Holmes. 2007. Coronavirus binding and entry, p. 3-31. In V. Thiel (ed.), Coronaviruses: molecular and cellular biology. Caister Academic Press, Norfolk, United Kingdom.
38. White, J. M., S. E. Delos, M. Brecher, and K. Schornberg. 2008. Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit. Rev. Biochem. Mol. Biol. 43:189-219.
39. Xiao, X., S. Chakraborti, A. S. Dimitrov, K. Gramatikoff, and D. S. Dimitrov. 2003. The SARS-CoV S glycoprotein: expression and functional characterization. Biochem. Biophys. Res. Commun. 312:1159-1164.
40. Zhang, H., G. Wang, J. Li, Y. Nie, X. Shi, G. Lian, W. Wang, X. Yin, Y. Zhao, X. Qu, M. Ding, and H. Deng. 2004. Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies. J. Virol. 78:6938-6945.